VariantPlex Pan Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, MSI, and TMB from 185 genes associated with various solid tumor malignancies.
VariantPlex Complete Solid Tumor is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, MSI, and TMB from 430 genes associated with various solid tumor malignancies.
Immunoverse is a research assay that characterizes the immune repertoire, including assessment of T- and B-cell clonalities and rare clones, and detection of tumor infiltrating lymphocytes (TIL) and somatic hypermutation with targeted NGS of key T cell receptor and B cell receptor chain RNA relevant for blood cancer and solid tumor research.
VariantPlex Myeloid is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and ITDs from 75 genes associated with acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS).
VariantPlex Core Myeloid is a research assay for targeted next generation sequencing of DNA for characterization of SNVs, indels, CNVs, and ITDs from 37 genes associated with acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS).
FusionPlex Pan Heme is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 199 genes associated with lymphoid and myeloid malignancies.
FusionPlex Heme V2 is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 87 genes associated with lymphoid and myeloid malignancies.
FusionPlex Myeloid is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 84 genes associated with myeloid-origin malignancies.
FusionPlex Lymphoma is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 125 genes associated with lymphomas.
FusionPlex ALL is a research assay for targeted next generation sequencing of RNA for characterization of variants, indels, expression, and fusions, including novel fusions, from 81 genes associated with acute lymphoblastic leukemia (ALL) .
Accumax Erlenmeyer Flask- the perfect solution for suspension culture of mammalian cells, plants, microbes and microorganisms. These flasks are not only ideal for containing, mixing and storing solutions, but also offer a safer alternative to glass. With their durable construction, they won't break, chip or shatter during the hustle and bustle of everyday lab work.
In-depth understanding of complete genome in human, aninal, plant and microbe with end-to-end services.
Sequencing only service for customer-premade libraries at different read lengths and capacities to suit any cost, project scale and turnaround with the world-leading, powerful, and sophisticated sequencing platforms (Illumina, Pacbio, and Oxford Nanopore).
16S/18S/ITS rRNA amplicon metagenomic sequencing employs universal primers to target specific regions to identify the phylogeny and taxonomy from complex microbiomes.
Single cell RNA sequencing uncovers the complexity of cellular diversity to employ the study of unusual cell types, cell-lineage associations, and samples of heterogeneous nature with 10x Genomics technology.
Phase Separator is a unique, new pipetting capability on the Fluent® Automation Workstation. This patented liquid separation technology can detect liquid-liquid interfaces and effectively separate neighbor phases while avoiding contamination. Suitable for removing the plasma phase from a centrifuged blood sample, it delivers up to double the speed of camera-based systems for plasma separation.
As the framework of stellar automation, Nucleus® Automation Infrastructure combines (A) your choice of stationary or mobile mounted collaborative robotic arms; (B) mobile cart or stationary table work surfaces to house your preferred devices; and (C) powerful Cellario™ Whole Lab Automation software. Unique MicroDock technology lets you effortlessly roll workflow devices in and out for space efficiency and manual device use.
The Prime® Automated Liquid Handler unites powerful features for a fully integrated approach to lab automation. Collaborative 2-armed robot transport and dynamic tray loading and pipetting facilitate rapid and continuous pipetting, while vertical orientation saves on lab space. Pipetting heads, including 96 Multi-Channel, 384 Multi-Channel, and Independent Z-8 Channel are easily changed out on the fly.
Cellario™ Whole Lab Automation Software invigorates any automated workflow. This integration software framework brilliantly organizes, schedules, and runs multi-device workflows, and also manages device utilization and performance. Cellario seamlessly integrates with most laboratory information management systems (LIMS) or other internal software and enables scalable automation across a single lab or an expansive enterprise.
Automated storage solutions from HighRes Biosolutions, including the SteriStore™ self-sterilizing automated incubator, AmbiStore™ random access ambient temperature sample storage carousel, and TundraStore™ automated low temperature freezer, protect sample integrity in standalone applications as well as when integrated into a fully walkaway Nucleus™ automation infrastructure.
Automated labware management devices from HighRes Biosolutions, including those to deliver, orient, place, and dispose microplates and other consumables, offer consistently high performances whether they are used as a stand-alone devices in concert with a Prime® automated liquid handler or similar, or integrated into a fully walkaway Nucleus® automation infrastructure.
High-efficiency cryogenic storage
Reliable long-term storage solution
Long Read Sequencing (LRS) service employs cutting-edge technologies such as Oxford Nanopore and PacBio platforms for decoding complex genomes, completing transcriptomes, exploring metagenomes, and investigating structural variations with unmatched precision.
RNA sequencing is applied for in-depth analysis of whole transcriptomes, encompasses coding and non-coding RNAs (long ncRNA, small RNA, and circle RNA,etc.) for diverse research needs.
